SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-033302
Filing Date
2021-02-09
Accepted
2021-02-09 07:14:04
Documents
17
Period of Report
2021-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d111779d8k.htm   iXBRL 8-K 49681
2 EX-3.1 d111779dex31.htm EX-3.1 194469
3 EX-3.2 d111779dex32.htm EX-3.2 192966
4 EX-99.1 d111779dex991.htm EX-99.1 13401
9 GRAPHIC g111779dsp001.jpg GRAPHIC 3970
  Complete submission text file 0001193125-21-033302.txt   747014

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lly-20210209.xsd EX-101.SCH 5583
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20210209_def.xml EX-101.DEF 15983
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20210209_lab.xml EX-101.LAB 27277
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20210209_pre.xml EX-101.PRE 17341
10 EXTRACTED XBRL INSTANCE DOCUMENT d111779d8k_htm.xml XML 11911
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 21603924
SIC: 2834 Pharmaceutical Preparations